| Literature DB >> 31919417 |
Yu-Min Huang1,2,3, Yuan-Wen Lee4,5, Yan-Jiun Huang1,6, Po-Li Wei7,8,9,10,11.
Abstract
The role of laparoscopic surgery for left-sided colon cancer has been supported by the results of randomized controlled trials. However, its benefits and disadvantages in the real world setting should be further assessed with population-based studies.The hospitalization data of patients undergoing open or laparoscopic surgery for left-sided colon cancer were sourced from the Taiwan National Health Insurance Research Database. Patient and hospital characteristics and perioperative outcomes including length of hospital stay, operation time, opioid use, blood transfusion, intensive care unit (ICU) admission, and use of mechanical ventilation were compared. The overall survival was also assessed. Patients undergoing laparoscopic surgery had shorter hospital stay (p < 0.0001) and less demand for opioid analgesia (p = 0.0005). Further logistic regression revealed that patients undergoing open surgery were 1.70, 2.89, and 3.00 times more likely to have blood transfusion, to be admitted to ICU, and to use mechanical ventilation than patients undergoing laparoscopic surgery. Operations performed in medical centers were also associated with less adverse events. The overall survival was comparable between the 2 groups.With adequate hospital quality and volume, laparoscopic surgery for left-sided colon cancer was associated with improved perioperative outcomes. The long-term survival was not compromised.Entities:
Mesh:
Year: 2020 PMID: 31919417 PMCID: PMC6952445 DOI: 10.1038/s41598-019-57059-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of patients according to types of surgery.
| Characteristics | Total (N = 667) | Open (N = 521) | Laparoscopic (N = 146) | ||||
|---|---|---|---|---|---|---|---|
| Mean (SD) or N (%) | Mean (SD) or N (%) | Mean (SD) or N (%) | |||||
| Age, years | 65.1 | (12.9) | 65.1 | (13.2) | 65.2 | (12.2) | 0.99 |
| <55 | 152 | (22.8) | 124 | (23.8) | 28 | (19.2) | 0.32 |
| 55–64 | 169 | (25.3) | 124 | (23.8) | 45 | (30.8) | |
| 65–74 | 160 | (24.0) | 125 | (24.0) | 35 | (24.0) | |
| ≥75 | 186 | (27.9) | 148 | (28.4) | 38 | (26.0) | |
| Male | 388 | (58.2) | 298 | (57.2) | 90 | (61.6) | 0.34 |
| Monthly income (NTD) | 0.14 | ||||||
| 0 (Dependent) | 212 | (31.8) | 168 | (32.3) | 44 | (30.1) | |
| 1–20000 | 145 | (21.7) | 106 | (20.4) | 39 | (26.7) | |
| 20000–29999 | 201 | (30.1) | 166 | (31.9) | 35 | (24.0) | |
| ≥30000 | 109 | (16.3) | 81 | (15.6) | 28 | (19.2) | |
| Residence area | 0.27 | ||||||
| Central city | 291 | (43.6) | 224 | (43.0) | 67 | (45.9) | |
| Suburban | 171 | (25.6) | 141 | (27.1) | 30 | (20.6) | |
| Countryside | 205 | (30.7) | 156 | (29.9) | 49 | (33.6) | |
| Comorbidity | |||||||
| Congestive heart failure | 21 | (3.2) | 18 | (3.5) | 3 | (2.1) | 0.59 |
| Cerebrovascular disease | 54 | (8.1) | 38 | (7.3) | 16 | (11.0) | 0.15 |
| Chronic pulmonary disease | 62 | (9.3) | 45 | (8.6) | 17 | (11.6) | 0.27 |
| Renal disease | 25 | (3.8) | 19 | (3.7) | 6 | (4.1) | 0.79 |
| Liver disease | 44 | (6.6) | 34 | (6.5) | 10 | (6.9) | 0.89 |
| Metastasis | 21 | (3.2) | 16 | (3.1) | 5 | (3.4) | 0.83 |
| Hypertension | 284 | (42.6) | 216 | (41.5) | 68 | (46.6) | 0.27 |
| Diabetes mellitus | 115 | (17.2) | 82 | (15.7) | 33 | (22.6) | 0.052 |
| Hospital | |||||||
| Medical center | 352 | (52.8) | 280 | (53.7) | 72 | (49.3) | 0.37 |
| Metropolitan hospital | 289 | (43.3) | 219 | (42.0) | 70 | (48.0) | |
| Local community hospital | 26 | (3.9) | 22 | (4.2) | 4 | (2.7) | |
Perioperative outcomes of the patients.
| Variables | Total (N = 667) | Open (N = 521) | Laparoscopic (N = 146) | ||||
|---|---|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | |||||
| Length of hospital stay (Days) | <0.0001 | ||||||
| ≤10 | 222 | (33.3) | 147 | (28.2) | 75 | (51.4) | |
| >10 | 445 | (66.7) | 374 | (71.8) | 71 | (48.6) | |
| Surgery time (Hours) | <0.0001 | ||||||
| ≤4 | 405 | (60.7) | 344 | (66.0) | 61 | (41.8) | |
| >4 | 262 | (39.3) | 177 | (34.0) | 85 | (58.2) | |
| Opioid use (MEQ) | 0.0005 | ||||||
| ≤15 | 349 | (52.3) | 254 | (48.8) | 95 | (65.1) | |
| >15 | 318 | (47.7) | 267 | (51.3) | 51 | (34.9) | |
| Blood transfusion | 0.02 | ||||||
| Yes | 183 | (27.4) | 154 | (29.6) | 29 | (19.9) | |
| No | 484 | (72.6) | 367 | (70.4) | 117 | (80.1) | |
| ICU admission | 0.0005 | ||||||
| Yes | 164 | (24.6) | 144 | (27.6) | 20 | (13.7) | |
| No | 503 | (75.4) | 377 | (72.4) | 126 | (86.3) | |
| Mechanical ventilation | 0.0009 | ||||||
| Yes | 122 | (18.3) | 109 | (20.9) | 13 | (8.9) | |
| No | 545 | (81.7) | 412 | (79.1) | 133 | (91.1) | |
Abbreviation: MEQ, morphine equivalent dose.
Relative risks of clinical outcomes.
| Variables | Blood transfusion | ICU admission | Mechanical ventilation |
|---|---|---|---|
| aOR (95% CI) | aOR (95% CI) | aOR (95% CI) | |
| Open surgery | 1.70 (1.06–2.75) | 2.89 (1.67–5.02) | 3.00 (1.59–5.67) |
| <55 | 1 | 1 | 1 |
| 55–64 | 0.85 (0.48–1.52) | 1.00 (0.50–1.99) | 1.27 (0.59–2.72) |
| 65–74 | 1.31 (0.74–2.34) | 2.52 (1.32–4.82) | 2.46 (1.18–5.12) |
| ≥75 | 2.83 (1.62–4.93) | 5.64 (3.00–10.61) | 4.86 (2.40–9.81) |
| Male | 0.48 (0.33–0.70) | 1.13 (0.76–1.69) | 0.96 (0.63–1.49) |
| Congestive heart failure | 1.29 (0.46–3.61) | 1.66 (0.59–4.67) | 2.46 (0.91–6.68) |
| Cerebrovascular disease | 0.88 (0.44–1.74) | 1.54 (0.80–2.98) | 1.35 (0.67–2.72) |
| Chronic pulmonary disease | 1.29 (0.70–2.36) | 0.88 (0.47–1.67) | 1.02 (0.52–2.01) |
| Renal disease | 2.68 (1.10–6.56) | 1.54 (0.59–4.04) | 1.31 (0.48–3.61) |
| Liver disease | 0.90 (0.43–1.91) | 0.97 (0.44–2.15) | 1.11 (0.49–2.53) |
| Metastasis | 3.12 (1.22–8.03) | 1.31 (0.43–4.01) | 3.95 (1.46–10.68) |
| Hypertension | 0.87 (0.57–1.31) | 0.80 (0.52–1.23) | 0.82 (0.51–1.31) |
| Diabetes mellitus | 1.29 (0.78–2.15) | 1.41 (0.83–2.40) | 1.35 (0.77–2.37) |
| Medical center | 1 | 1 | 1 |
| Metropolitan hospital | 1.53 (1.05–2.23) | 2.90 (1.93–4.36) | 1.70 (1.10–2.61) |
| Local community hospital | 4.71 (1.95–11.39) | 1.63 (0.62–4.28) | 0.68 (0.21–2.28) |
Abbreviation: aOR, adjusted odds ratio.
Figure 1Kaplan-Meier curves of overall survival.